Grants and Contracts Details
Lysophosphatidic acid (LPA) is a bioactive lipid mediator that is found in abundance in atherosclerotic plaques and whose production is accelerated by activated platelets. In isolated or cultured systems, LPA stimulates a wide variety of vascular cell responses, including phenotypic modulation of vascular smooth muscle cells (VSMCs), by acting at least in part through a family of G-protein coupled receptors. Thus, LPA is positioned to play a pivotal role in the development of atherosclerosis and restenosis following arterial injury, and using LPA receptor deficient mice, I have recently established the first pathophysiologic role for endogenous LPA in the vasculature. The actions of local and circulating LPA may be terminated by enzymatic dephosphorylation of the lipid by a family of hexahelical membrane spanning proteins, termed lipid phosphate phosphatases (LPP). Of the three LPP enzymes with preference for LPA, LPP3 appears the most likely to play a biologic role in regulating LPA levels, and deficiency of LPP3 results in embyronic lethality in mice due to vascular and neural tube defects. My long-range goal is to provide a better understanding of the role of LPA signaling in the vasculature. The objective of this proposal is to define the molecular events that are initiated by LPP3 in VSMCs and to assess their contribution to the vascular injury response. Based on my preliminary data, my central hypothesis is that LPP3 terminates Rho-dependent migration and dedifferentiation of VSMCs triggered by exposure to LPA . To test my hypothesis, I have generated a range of useful reagents to study LPP3, including a recombinant lentivirus for efficient expression in VSMCs, engineered micro RNAs that target the mRNA of this protein for degradation, and transgenic mice that lack LPP3 in smooth muscle cells. In Specific Aim One, I will test my hypothesis in isolated VSMCs and determine the consequences of up- and down-regulation of LPP3 on phenotypic modulation of cultured VSMCs. In Specific Aim Two, I will test my hypothesis by defining the role of LPP3 in the arterial injury response and neointimal formation using a well characterized mouse model of arterial denudation injury. My results should provide specific insight into signaling systems mediated by LPA and may provide novel targets for treatment and prevention of vascular disorders.
|Effective start/end date||7/1/09 → 6/30/10|
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.